Marijke Kamsteeg

2.7k total citations
33 papers, 1.4k citations indexed

About

Marijke Kamsteeg is a scholar working on Dermatology, Physiology and Immunology and Allergy. According to data from OpenAlex, Marijke Kamsteeg has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Dermatology, 17 papers in Physiology and 17 papers in Immunology and Allergy. Recurrent topics in Marijke Kamsteeg's work include Dermatology and Skin Diseases (25 papers), Allergic Rhinitis and Sensitization (17 papers) and Asthma and respiratory diseases (16 papers). Marijke Kamsteeg is often cited by papers focused on Dermatology and Skin Diseases (25 papers), Allergic Rhinitis and Sensitization (17 papers) and Asthma and respiratory diseases (16 papers). Marijke Kamsteeg collaborates with scholars based in Netherlands, United States and Germany. Marijke Kamsteeg's co-authors include Gil Mor, Joost Schalkwijk, Patrick L.J.M. Zeeuwen, Ivonne M.J.J. van Vlijmen‐Willems, Thomas Rutherford, Diana Rodijk‐Olthuis, Bozena Hanczaruk, Vikki M. Abrahams, Geuranne S. Tjabringa and Patrick A.M. Jansen and has published in prestigious journals such as PLoS ONE, Oncogene and American Journal Of Pathology.

In The Last Decade

Marijke Kamsteeg

33 papers receiving 1.4k citations

Peers

Countries citing papers authored by Marijke Kamsteeg

Since Specialization

Citations

This map shows the geographic impact of Marijke Kamsteeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke Kamsteeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke Kamsteeg more than expected).

Fields of papers citing papers by Marijke Kamsteeg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke Kamsteeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke Kamsteeg. The network helps show where Marijke Kamsteeg may publish in the future.

Co-authorship network of co-authors of Marijke Kamsteeg

This figure shows the co-authorship network connecting the top 25 collaborators of Marijke Kamsteeg. A scholar is included among the top collaborators of Marijke Kamsteeg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijke Kamsteeg. Marijke Kamsteeg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug Survival of Dupilumab, Methotrexate, and Cyclosporine A in Children With Atopic Dermatitis 2024 ·JAMA Dermatology ·(unknown), (unknown), Marie L. A. Schuttelaar, (unknown), Marieke M.B. Seyger, (unknown), Nicolaas P. A. Zuithoff, (unknown), Marijke Kamsteeg, Marjolein de Bruin‐Weller, Suzanne G.M.A. Pasmans, Maritza A. Middelkamp‐Hup, Marlies de Graaf	1
2	Effectiveness of systemic treatments on pruritus associated with atopic dermatitis: A systematic review in pediatric patients 2023 ·Pediatric Dermatology ·T. Kouwenhoven, (unknown), P.C.M. van de Kerkhof, E.M.G.J. de Jong, Marijke Kamsteeg, Marieke M.B. Seyger	3
3	Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry 2023 ·Acta Dermato Venereologica ·Celeste M. Boesjes, (unknown), Nicolaas P. A. Zuithoff, Daphne S. Bakker, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Marlies de Graaf, Marjolein de Bruin‐Weller	16
4	Gabapentin and oral antidepressants for chronic pruritus: a prospective cohort study evaluating efficacy and side effects in daily dermatological practice 2023 ·Journal of Dermatological Treatment ·T. Kouwenhoven, P.C.M. van de Kerkhof, Marijke Kamsteeg	2
5	Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry 2023 ·British Journal of Dermatology ·Lotte S. Spekhorst, Celeste M. Boesjes, Laura Loman, Nicolaas P. A. Zuithoff, Daphne S. Bakker, (unknown), Marijke Kamsteeg, Inge Haeck, Albert J. Oosting, P.P.M. van Lümig, (unknown), Ron A. Tupker, Annebeth Flinterman, F.M. Garritsen, (unknown), Marjolein de Bruin‐Weller, Marie L. A. Schuttelaar, Marlies de Graaf	20
6	Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry 2022 ·Acta Dermato Venereologica ·Celeste M. Boesjes, (unknown), Nicolaas P. A. Zuithoff, Daphne S. Bakker, Laura Loman, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, (unknown), F.M. Garritsen, Klaziena Politiek, J Oldhoff, Marlies de Graaf, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller	12
7	Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis 2022 ·Acta Dermato Venereologica ·(unknown), Chantal van Luijk, (unknown), Daphne S. Bakker, Lotte S. Spekhorst, Nicolaas P. A. Zuithoff, Marie L. A. Schuttelaar, Geertruida L. E. Romeijn, Angelique N. Voorberg, Marijke Kamsteeg, Inge Haeck, Marlies de Graaf, Judith L. Thijs, Joke de Boer, Marjolein de Bruin‐Weller	13
8	Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry 2020 ·Journal of the American Academy of Dermatology ·Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst, Daphne S. Bakker, Geertruida L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Angelique N. Voorberg, Albert J. Oosting, (unknown), (unknown), Inge Haeck, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller	63
9	Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides 2019 ·Journal of Investigative Dermatology ·Jos P.H. Smits, Thomas H. A. Ederveen, Gijs Rikken, (unknown), Ivonne M.J.J. van Vlijmen‐Willems, Jos Boekhorst, Marijke Kamsteeg, Joost Schalkwijk, Sacha A. F. T. van Hijum, Patrick L.J.M. Zeeuwen, Ellen H. van den Bogaard	67
10	214 TARgeting the cutaneous microbiota in atopic dermatitis by coal tar via AHR-dependent induction of antimicrobial peptides 2019 ·Journal of Investigative Dermatology ·(unknown), Thomas H. A. Ederveen, Gijs Rikken, (unknown), (unknown), Jos Boekhorst, Marijke Kamsteeg, Joost Schalkwijk, Sacha A. F. T. van Hijum, Patrick L.J.M. Zeeuwen, Ellen H. van den Bogaard	5
11	Use of Systemic Treatment in Patients with Chronic Pruritus: A Survey of Dermatologists in the Netherlands 2018 ·Acta Dermato Venereologica ·T. Kouwenhoven, Peter L. M. Kerkhof, Marijke Kamsteeg	3
12	Use of oral antidepressants in patients with chronic pruritus: A systematic review 2017 ·Journal of the American Academy of Dermatology ·T. Kouwenhoven, P.C.M. van de Kerkhof, Marijke Kamsteeg	54
13	Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair 2012 ·British Journal of Dermatology ·Heleen D. de Koning, Ellen H. van den Bogaard, Judith G.M. Bergboer, Marijke Kamsteeg, Ivonne M.J.J. van Vlijmen‐Willems, Kiyotaka Hitomi, Julie Henry, Michel Simon, (unknown), Akemi Ishida‐Yamamoto, Joost Schalkwijk, Patrick L.J.M. Zeeuwen	66
14	Type 2 Helper T-Cell Cytokines Induce Morphologic and Molecular Characteristics of Atopic Dermatitis in Human Skin Equivalent 2011 ·American Journal Of Pathology ·Marijke Kamsteeg, Mieke Bergers, (unknown), Patrick L.J.M. Zeeuwen, Stanleyson V. Hato, Joost Schalkwijk, Geuranne S. Tjabringa	63
15	Expression of the Vanin Gene Family in Normal and Inflamed Human Skin: Induction by Proinflammatory Cytokines 2009 ·Journal of Investigative Dermatology ·Patrick A.M. Jansen, Marijke Kamsteeg, Diana Rodijk‐Olthuis, Ivonne M.J.J. van Vlijmen‐Willems, Gys J. de Jongh, Mieke Bergers, Geuranne S. Tjabringa, Patrick L.J.M. Zeeuwen, Joost Schalkwijk	69
16	Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis 2009 ·British Journal of Dermatology ·Marijke Kamsteeg, Patrick A.M. Jansen, Ivonne M.J.J. van Vlijmen‐Willems, P.E.J. van Erp, Diana Rodijk‐Olthuis, P.G. van der Valk, Thijs Feuth, Patrick L.J.M. Zeeuwen, Joost Schalkwijk	74
17	Genetically Programmed Differences in Epidermal Host Defense between Psoriasis and Atopic Dermatitis Patients 2008 ·PLoS ONE ·Patrick L.J.M. Zeeuwen, Gys J. de Jongh, Diana Rodijk‐Olthuis, Marijke Kamsteeg, Renate M. Verhoosel, Michelle M. van Rossum, Pieter S. Hiemstra, Joost Schalkwijk	37
18	Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells 2003 ·Oncogene ·Marijke Kamsteeg, Thomas Rutherford, Eva Sapi, Bozena Hanczaruk, (unknown), Maryann B. Flick, David Brown, Gil Mor	148
19	The Fas/Fas Ligand System and Cancer: Immune Privilege and Apoptosis 2003 ·Molecular Biotechnology ·Vikki M. Abrahams, Marijke Kamsteeg, Gil Mor	47
20	Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis 2002 ·Biochemical Pharmacology ·Gil Mor, (unknown), Marijke Kamsteeg	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact